Prairiewood Capital LLC Has $884,000 Stock Holdings in Cigna Co. (NYSE:CI)

Prairiewood Capital LLC lessened its holdings in Cigna Co. (NYSE:CIGet Rating) by 2.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,689 shares of the health services provider’s stock after selling 86 shares during the period. Prairiewood Capital LLC’s holdings in Cigna were worth $884,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of CI. Comprehensive Financial Consultants Institutional Inc. purchased a new stake in shares of Cigna during the fourth quarter worth $78,000. Benjamin Edwards Inc. raised its holdings in shares of Cigna by 150.9% during the fourth quarter. Benjamin Edwards Inc. now owns 138 shares of the health services provider’s stock worth $32,000 after acquiring an additional 83 shares in the last quarter. Westwood Holdings Group Inc. raised its holdings in shares of Cigna by 20.9% during the fourth quarter. Westwood Holdings Group Inc. now owns 7,749 shares of the health services provider’s stock worth $1,779,000 after acquiring an additional 1,340 shares in the last quarter. Kestra Advisory Services LLC raised its holdings in shares of Cigna by 3.8% during the fourth quarter. Kestra Advisory Services LLC now owns 18,572 shares of the health services provider’s stock worth $4,265,000 after acquiring an additional 685 shares in the last quarter. Finally, Janney Montgomery Scott LLC raised its holdings in shares of Cigna by 17.1% during the fourth quarter. Janney Montgomery Scott LLC now owns 44,962 shares of the health services provider’s stock worth $10,325,000 after acquiring an additional 6,562 shares in the last quarter. 88.57% of the stock is owned by institutional investors and hedge funds.

CI stock opened at $263.52 on Friday. Cigna Co. has a twelve month low of $191.74 and a twelve month high of $273.58. The company has a market cap of $83.61 billion, a PE ratio of 16.35, a price-to-earnings-growth ratio of 1.05 and a beta of 0.77. The business’s 50-day simple moving average is $258.31 and its 200 day simple moving average is $243.84. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67.

Cigna (NYSE:CIGet Rating) last released its earnings results on Friday, May 6th. The health services provider reported $6.01 earnings per share for the quarter, topping analysts’ consensus estimates of $5.13 by $0.88. Cigna had a return on equity of 15.31% and a net margin of 3.04%. The business had revenue of $44.01 billion for the quarter, compared to the consensus estimate of $43.48 billion. During the same period last year, the business earned $4.73 earnings per share. The firm’s revenue for the quarter was up 7.4% compared to the same quarter last year. On average, equities research analysts anticipate that Cigna Co. will post 22.71 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 23rd. Stockholders of record on Wednesday, June 8th were issued a $1.12 dividend. This represents a $4.48 annualized dividend and a dividend yield of 1.70%. The ex-dividend date was Tuesday, June 7th. Cigna’s payout ratio is currently 27.79%.

CI has been the subject of several recent research reports. Sanford C. Bernstein increased their price objective on Cigna from $258.00 to $301.00 and gave the stock a “mkt perform” rating in a report on Friday, May 27th. Mizuho raised their target price on Cigna from $266.00 to $291.00 in a report on Monday, May 9th. StockNews.com initiated coverage on Cigna in a report on Thursday, March 31st. They set a “strong-buy” rating on the stock. Deutsche Bank Aktiengesellschaft raised their target price on Cigna from $236.00 to $284.00 in a report on Thursday, June 9th. Finally, JPMorgan Chase & Co. upgraded Cigna from a “neutral” rating to an “overweight” rating and raised their target price for the company from $248.00 to $304.00 in a report on Monday, May 16th. Six investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $289.12.

In other Cigna news, insider Jason D. Sadler sold 5,000 shares of the company’s stock in a transaction on Wednesday, April 6th. The shares were sold at an average price of $250.00, for a total transaction of $1,250,000.00. Following the completion of the sale, the insider now owns 31,749 shares in the company, valued at approximately $7,937,250. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Eric P. Palmer sold 8,126 shares of the business’s stock in a transaction on Wednesday, April 6th. The shares were sold at an average price of $250.00, for a total transaction of $2,031,500.00. Following the completion of the transaction, the chief executive officer now directly owns 40,942 shares of the company’s stock, valued at approximately $10,235,500. The disclosure for this sale can be found here. Insiders sold a total of 135,830 shares of company stock worth $36,128,528 over the last three months. 0.80% of the stock is owned by company insiders.

Cigna Company Profile (Get Rating)

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

Institutional Ownership by Quarter for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.